These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 447808)

  • 1. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.
    Wisgerhof M; Brown RD
    J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
    Williams GH; Dluhy RG; Moore TJ
    Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
    Wisgerhof M; Carpenter PC; Brown RD
    J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone metabolic clearance is normal in low-renin essential hypertension.
    Brown RD
    J Clin Endocrinol Metab; 1976 Apr; 42(4):661-6. PubMed ID: 1262441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone and renin in essential hypertension.
    Genest J; Nowaczynski W; Boucher R; Kuchel O; Rojo-Ortega JM
    Can Med Assoc J; 1975 Sep; 113(5):421-31. PubMed ID: 1098756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma aldosterone and angiotensin II before and after noradrenergic inhibition in normal subjects and patients with mild essential hypertension.
    Beretta-Piccoli C; Weidmann P; Boehringer K; Link L; Bianchetti MG; Morton JJ
    J Clin Endocrinol Metab; 1984 Aug; 59(2):316-20. PubMed ID: 6736206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension.
    Marks AD; Marks DB; Kanefsky TM; Adlin VE; Channick BJ
    J Clin Endocrinol Metab; 1979 Feb; 48(2):266-70. PubMed ID: 429480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
    Anderson GH; Howland T; Domschek R; Streeten DH
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension.
    Ruilope LM; Miranda B; Robles RG; Hammond TG; Sancho J; Romero JC; Rodicio JL
    Postgrad Med J; 1986; 62 Suppl 1():90-3. PubMed ID: 3534868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
    Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R
    J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decreased metabolic clearance rate of aldosterone in benign essential hypertension.
    Nowaczynski W; Kuchel O; Genest J
    J Clin Invest; 1971 Oct; 50(10):2184-90. PubMed ID: 5116208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats.
    Roesch DM; Tian Y; Zheng W; Shi M; Verbalis JG; Sandberg K
    Endocrinology; 2000 Dec; 141(12):4629-36. PubMed ID: 11108277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased aldosterone/renin quotient in obese hypertensive women: a novel role for low-density lipoproteins?
    Lamounier-Zepter V; Rotthoff T; Ansurudeen I; Kopprasch S; Scherbaum WA; Ehrhart-Bornstein M; Bornstein SR
    Horm Metab Res; 2006 Jul; 38(7):471-5. PubMed ID: 16933186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-aldosterone axis in ethanol intoxication: effect of A II infusion.
    Nieminen MM; Linkola J; Fyhrquist F; Tikkanen I; Forslund T
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):137-40. PubMed ID: 2987138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between aldosterone and bradykinin.
    Mersey JH; Williams GH; Hollenberg NK; Dluhy RG
    Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted aldosterone responsiveness to angiotensin II in normotensive subjects with familial predisposition to essential hypertension.
    Beretta-Piccoli C; Pusterla C; Städler P; Weidmann P
    J Hypertens; 1988 Jan; 6(1):57-61. PubMed ID: 3351294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.